Supervised risk predictor of breast cancer based on intrinsic subtypes

Journal of Clinical Oncology

Volumn 27, Issue 8, 2009, Pages 1160-1167

  Bernard, Philip S ^a   Parker, Joel S ^b   Mullins, Michael ^b   Cheung, Maggie C U ^b   Leung, Samuel ^b   Voduc, David ^b   Vickery, Tammi ^b   Davies, Sherri ^b   Fauron, Christiane ^b   He, Xiaping ^b   Hu, Zhiyuan ^b   Quackenhush, John F ^b   Stijleman, Inge J ^b   Palazzo, Juan ^b   Matron, J S ^b   Nobel, Andrew B ^b   Mardis, Elaine ^b   Nielsen, Torsten O ^b   Ellis, Matthew J ^b   Perou, Charles M ^b  

^a UNIVERSITY OF UTAH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUOROURACIL; PACLITAXEL; TAXANE DERIVATIVE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; C INDEX; CANCER GRADING; CANCER RISK; CANCER SIZE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA MICROARRAY; DRUG EFFICACY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUMINAL SUBTYPE A; LUMINAL SUBTYPE B; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOLECULAR SUBTYPING; MOLECULAR TYPING; ONCOGENE; ONCOGENE NEU; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SCORING SYSTEM; TREATMENT RESPONSE;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK;

EID: 62449131093     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.1370     Document Type: Article

References (31)

1. Sorlie T, Perou CM, Tibshirani R, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.Proc Natl Acad Sci U S A 98:10869-10874, 2001
2. van't Veer LJ, Dai H, van de Vijver MJ, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536, 2002
3. van'tVeerLJ, PaikS, Hayes DF: Gene expression profiling of breast cancer: A new tumor marker. J Clin Oncol 23:1631-1635, 2005
4. Paik S, Shak S, Tang G, et al: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826, 2004
5. Paik S, Tang G, Shak S, et al: Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24:3726-3734, 2006
6. Hu Z, Fan C, Oh DS, et al: The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96, 2006
7. Loi S, Haibe-Kains B, Desmedt C, et al: Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 25:1239-1246, 2007
8. Perreard L, Fan C, Quackenbush JF, et al: Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res 8:R23, 2006p9. Sotiriou C, Wirapati P, Loi S, et al: Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98:262-272, 2006
9. Perou CM, Sorlie T, Eisen MB, etal: Molecular portraits of human breast tumours. Nature 406:747-752, 2000
10. Sorlie T, Tibshirani R, Parker J, etal: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100:8418-8423, 2003
11. Fan C, Oh DS, Wessels L, et al: Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560-569, 2006
12. van de Vijver MJ, He YD, van't Veer LJ, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009, 2002
13. Wang Y, Klijn JG, Zhang Y, et al: Geneexpression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671-679, 2005
14. Ivshina AV, George J, Senko O, et al: Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66: 10292-10301, 2006
15. Hess KR, Anderson K, Symmans WF, et al: Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol 24:4236-4244, 2006
16. University of North Carolina Microarray Database: GEO Data Sets for Breast Cancer Research Published Papers (Clinical Data updated on 11-06-2007 for Data I, 4-7-2008 for Data II). https://genome.unc.edu/pubsup/breastGEO/
17. National Center for Biotechnology Information: Gene expression omnibus, http://www.ncbi.nlm.nih.gov/geo/
18. Eisen MB, Spellman PT, Brown PO, et al: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:14863-14868, 1998
19. Yufeng L, Hayes DL, Nobel A, et al: Statistical significance of clustering for high dimension low sample size data. J Am Stat Assoc 103:1281-1293,2008
20. Mullins M, Perreard L, Quackenbush JF, et al: Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin fixed, paraffin-embedded tissues. Clin Chem 53: 1273-1279, 2007
21. Storey JD, Tibshirani R: Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol Biol 224:149-157,2003
22. Dudoit S, Fridlyand J: A prediction-based resampling method for estimating the number of clusters in a dataset. Genome Biol 3:RE-SEARCH0036, 2002
23. Tibshirani R, Hastie T, Narasimhan B, et al: Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 99:6567-6572, 2002
24. Dabney AR: Classification of microarrays to nearest centroids. Bioinformatics 214-1484154, 2005
25. Chaudhuri P, Marron JS: SiZer for exploration of structures in curves. J Am Stat Assoc 94:807-823, 1999
26. Sheather SJ, Jones MC: A reliable data-based bandwidth selection method for kernel density estimation. J R Stat Soc 53:683-690, 1991
27. The Design Library: C-index. http://lib.stat.emu.edu/S/Harrell/Design. html
28. Neve RM, Chin K, Fridlyand J, et al: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515-527, 2006
29. Rouzier R, Pusztai L, Delaloge S, et al: Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemo-therapy for breast cancer. J Clin Oncol 23:8331-8339,2005
30. Harris LN, You F, Schnitt SJ, et al: Predictors of resistance to preoperative trastuzumab and vinorelbine for HEF!2-positive early breast cancer. Clin Cancer Res 13:1198-1207, 2007
31. Herschkowitz JI, Simin K, Weigman VJ, et al: dentification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8:R76, 2007